Management of Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS)

Initial Assessment and Diagnosis

• The European Society of Cardiology recommends immediate treatment for presumed Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) with dual antiplatelet therapy, anticoagulation, continuous cardiac monitoring, and urgent cardiology consultation for risk stratification and potential invasive management in patients with active chest pain and troponin elevation 1, 2
• A troponin level of 0.38 ng/mL is significantly elevated above the 99th percentile upper limit of normal, confirming myocardial injury in the setting of active chest pain, according to the European Heart Journal 1, 2
• Obtain a 12-lead ECG immediately to assess for ST-segment elevation, ST-segment depression, T-wave inversions, or pseudonormalization of previously inverted T-waves, as recommended by the European Heart Journal 1, 3

Immediate Medical Therapy

• The American Heart Association recommends initiating aspirin 150-325 mg orally (chewed) for immediate platelet inhibition in patients with NSTE-ACS 5
• The European Society of Cardiology recommends anticoagulation with unfractionated heparin bolus and infusion, or low-molecular-weight heparin (enoxaparin 1 mg/kg subcutaneously) in patients with NSTE-ACS 1, 5
• Beta-blocker therapy (e.g., metoprolol 25-50 mg orally) is recommended unless contraindicated by heart failure, hypotension, or bradycardia, according to the European Heart Journal 1, 5

Risk Stratification and Monitoring

• The European Society of Cardiology recommends calculating the GRACE or TIMI risk score to determine the urgency of invasive strategy in patients with NSTE-ACS 1, 6
• Place patients on continuous cardiac telemetry monitoring until NSTE-ACS is definitively ruled out or treated, as recommended by the American Heart Association 5, 3

Critical Differential Diagnoses to Consider

• The European Society of Cardiology recommends actively excluding life-threatening mimics such as aortic dissection, pulmonary embolism, myocarditis, or Takotsubo cardiomyopathy in patients with presumed NSTE-ACS 1, 2, 4
• Aortic dissection should be considered if there is clinical suspicion, and nitroglycerin is contraindicated if dissection is present, according to the European Heart Journal 1, 2

Timing of Invasive Strategy

• The European Society of Cardiology recommends immediate (<2 hours) coronary angiography for patients with refractory chest pain, hemodynamic instability, cardiogenic shock, life-threatening arrhythmias, or mechanical complications 1
• Urgent (2-24 hours) coronary angiography is recommended for patients with dynamic ECG changes, ongoing chest pain despite medical therapy, elevated troponin with GRACE score >140, or diabetes mellitus, according to the European Heart Journal 1, 2

Common Pitfalls to Avoid

• The European Society of Cardiology recommends not dismissing troponin elevation as "chronic" or due to renal dysfunction without thorough evaluation, as cardiac conditions are the primary contributors to troponin elevation even in renal failure 1, 2
• Antiplatelet and anticoagulation therapy should not be delayed while awaiting troponin trends, as treatment should begin immediately in patients with active chest pain and any troponin elevation, according to the European Heart Journal 1, 5